人类免疫缺陷病毒感染者减重手术结局:ATHENA队列回顾性分析
该研究基于荷兰ATHENA队列回顾性分析51例接受抗逆转录病毒治疗的HIV感染者减重术后18个月结局。85%患者实现>20%总体重丢失,平均较基线下降33.5%(95%CI -37.7%至-29.3%)。血脂显著改善(P<.01),病毒学失败1例,无明确不良病毒学结局关联。
要点
- 51例HIV感染者减重术后18个月,85%实现>20%总体重丢失,平均下降33.5%。
- 确认病毒学失败1例、病毒短暂波动3例,未发现与不良病毒学结局明确关联。
- 血脂显著改善(P<.01),血清肌酐和血压未显著改善,总用药和肥胖相关合并用药减少。
核心结论
- 在该队列中,减重手术是接受抗逆转录病毒治疗的HIV感染者体重控制和血脂管理的有效干预,未发现与不良病毒学结局的明确关联。
研究设计与样本
- 基于荷兰ATHENA队列的回顾性分析,纳入来自荷兰所有HIV治疗中心的51例HIV感染者,随访至减重术后18个月。
主要发现
- 51例患者中,减重术后18个月内确认病毒学失败1例、病毒短暂波动3例。
- 85%患者减重术后18个月实现>20%总体重丢失,平均较基线差异为-33.5%(95%CI -37.7%至-29.3%)。
- 所测抗逆转录病毒药物谷浓度均高于最低有效浓度,仅1份达芦那韦样本例外。
- 减重术后血脂谱显著改善(P<.01),血清肌酐和血压未显著改善。
- 减重术后18个月总用药从203种降至103种,肥胖相关合并用药从62种降至25种。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The implications of bariatric surgery (BS) on virologic and metabolic outcomes in people with human immunodeficiency virus (HIV; PWH) on antiretroviral therapy (ART) are unknown. METHODS: Here, we report a retrospective analysis up to 18 months post-BS in PWH from the AIDS Therapy evaluation in The Netherlands (ATHENA) cohort with data from all dutch HIV treating Centers. Primary end points were a confirmed virologic failure (2 consecutive HIV-RNA measurements >200 copies/mL) and the percentage of patients who achieved >20% total body weight loss up to 18 months post-BS. Switches from baseline ART and trough plasma concentrations of antiretrovirals were also reported post-BS. Metabolic parameters and medication usage were compared pre- and post-BS. RESULTS: Fifty-one patients were included. One case of confirmed virologic failure and 3 cases with viral blips were detected in this cohort up to 18 months post-BS. Eighty-five percent of patients achieved >20% total body weight loss at 18 months post-BS, with a mean difference from baseline (95% confidence interval) of -33.5% (-37.7% to -29.3%). Trough plasma concentrations of measured antiretroviral agents were all above minimum effective concentrations, except for 1 sample of darunavir. Lipid profiles, but not serum creatinine and blood pressure, improved significantly (P < .01) post-BS. Total medications and obesity-related comedications declined from 203 to 103 and from 62 to 25, respectively, at 18 months post-BS. CONCLUSIONS: BS was an effective intervention for weight loss and lipid control in PWH using ART in this cohort with no clear link to poor virologic outcomes.
引用
- Zino L, Wit F, Rokx C, et al. Outcomes of Bariatric Surgery in People With Human Immunodeficiency Virus: A Retrospective Analysis From the ATHENA Cohort. Clin Infect Dis. 2023. PMID: 37392435. doi:10.1093/cid/ciad404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。